Paldino, E.; D’Angelo, V.; Laurenti, D.; Angeloni, C.; Sancesario, G.; Fusco, F.R.
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease. Cells 2020, 9, 2286.
https://doi.org/10.3390/cells9102286
AMA Style
Paldino E, D’Angelo V, Laurenti D, Angeloni C, Sancesario G, Fusco FR.
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease. Cells. 2020; 9(10):2286.
https://doi.org/10.3390/cells9102286
Chicago/Turabian Style
Paldino, Emanuela, Vincenza D’Angelo, Daunia Laurenti, Cecilia Angeloni, Giuseppe Sancesario, and Francesca R. Fusco.
2020. "Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease" Cells 9, no. 10: 2286.
https://doi.org/10.3390/cells9102286
APA Style
Paldino, E., D’Angelo, V., Laurenti, D., Angeloni, C., Sancesario, G., & Fusco, F. R.
(2020). Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease. Cells, 9(10), 2286.
https://doi.org/10.3390/cells9102286